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Background: Regression discontinuity designs are non-randomized 
study designs that permit strong causal inference with relatively 
weak assumptions. Interest in these designs is growing but there is 
limited knowledge of the extent of their application in health. We 
aimed to conduct a comprehensive systematic review of the use of 
regression discontinuity designs in health research.
Methods: We included studies that used regression discontinuity 
designs to investigate the physical or mental health outcomes of 
any interventions or exposures in any populations. We searched 32 
health, social science, and gray literature databases (1 January 1960 
to 1 January 2019). We critically appraised studies using eight cri-
teria adapted from the What Works Clearinghouse Standards for re-
gression discontinuity designs. We conducted a narrative synthesis, 
analyzing the forcing variables and threshold rules used in each study.
Results: The literature search retrieved 7658 records, producing 325 
studies that met the inclusion criteria. A broad range of health topics was 
represented. The forcing variables used to implement the design were 
age, socioeconomic measures, date or time of exposure or implementa-
tion, environmental measures such as air quality, geographic location, and 
clinical measures that act as a threshold for treatment. Twelve percent of 
the studies fully met the eight quality appraisal criteria. Fifteen percent of 
studies reported a prespecified primary outcome or study protocol.
Conclusions: This systematic review demonstrates that regression 
discontinuity designs have been widely applied in health research 
and could be used more widely still. Shortcomings in study quality 
and reporting suggest that the potential benefits of this method have 
not yet been fully realized.
Keywords: Evaluation; Intervention; Natural experiment; Policy; 
Regression discontinuity; Systematic review
(Epidemiology 2021;32: 87–93)
Regression discontinuity designs are of increasing interest in epidemiology as a method of analyzing natural experiments, 
evaluating interventions, and supporting causal inference in the 
absence of randomized trials.1 Thistlethwaite and Campbell 
(1960) first proposed the regression discontinuity design based 
on the insight that, given an eligibility rule based on a cutoff 
value for a continuous variable whose measurement cannot be 
precisely manipulated by participants or administrators, treat-
ment assignment for participants close to the threshold value 
will be effectively random; therefore, the causal effect of the 
treatment can be estimated by comparing outcomes for groups 
just above and just below the cutoff, without any bias due to un-
observed confounding.2,3 Regression discontinuity designs are 
attractive because they allow the evaluation of causal effects of 
interventions or exposures using real-world data; furthermore, 
the method requires relatively weak assumptions that can be 
empirically tested.4 The ability to assign participants to an inter-
vention based on risk, severity, or need is a potential advantage 
over a randomized controlled trial design in terms of accepta-
bility to stakeholders and ethical requirements.5 The main limi-
tation of the design noted in the literature is the need for larger 
sample sizes than in randomized experiments.6,7
Following its initial presentation in the 1960s, uptake of 
the design was limited, partly due to a belief that few situations 
existed in which it could be applied.8 Two reviews of the design 
in health have identified a small number of applications. Mos-
coe et al9 identified 32 studies from medicine, epidemiology, 
or public health that used regression discontinuity designs. Ac-
cordingly, they argued that the design is likely under-used in 
these fields. A limitation of the review was that the search was 
restricted to a single database (PubMed). Venkataramani et al10 
presented 13 studies as examples of the regression disconti-
nuity design in healthcare and as support for their assertion 
that the design could be applied usefully and widely in clinical 
medicine and health policy; this review was nonsystematic.
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We aimed to conduct a comprehensive systematic re-
view to determine how regression discontinuity designs have 
been used to analyze the health effects of interventions or nat-
ural experiments. Our objectives were: (1) to map the use of 
regression discontinuity designs in settings and policy areas 
relevant to public health; (2) to identify what forcing variables 
have been used and what interventions or exposures have been 
investigated with these designs; and (3) to assess the quality 
of reporting of health-related regression discontinuity design 
studies.
METHODS
We published the review protocol in the PROSPERO 
international prospective register of systematic reviews (ref-
erence number CRD42015025117).
Inclusion Criteria
We included primary, empirical studies from any field 
of research that (1) reported an analysis which the authors 
described as regression discontinuity and (2) had an out-
come that measured any aspect of physical or mental health 
or wellbeing.
Search Strategy
We searched 32 health and social science databases for 
records containing the phrase “regression discontinuity” or 
“regression-discontinuity” in title, abstract, keyword, or full 
text (see eTable 1; http://links.lww.com/EDE/B738 in the sup-
plemental digital content for the list of databases and search 
strategies). The databases were selected to ensure coverage 
of disciplines relevant to social determinants of health and to 
public policy, particularly those such as education and eco-
nomics in which regression discontinuity designs are more 
commonly used. The date range covered was 1 January 1960 
(year of first publication describing the design) to 1 January 
2019 (last update search conducted in week 1 of March 2019). 
No language restrictions were applied. We examined refer-
ence lists of review articles and included studies to identify 
additional studies.
Study Selection
Retrieved references were compiled in an EndNote X7 
library and duplicates were manually removed. A random 
10% sample (random number sequence generated in Stata 
version 13) was screened independently for eligibility by two 
reviewers (M.H.B. and H.T.) based on the record title and ab-
stract. We resolved disagreements by discussion. We recorded 
reasons for exclusion of studies in EndNote.
Data Extraction
A coding framework was designed to record infor-
mation about the publication, research topic, study design, 
outcomes, country of first author’s institution, and country 
of data source. We described the implementation of regres-
sion discontinuity in each study in terms of the forcing var-
iable used, the intervention or exposure under investigation, 
the health-related outcome(s) measured, whether a primary 
outcome was specified, and whether a study protocol was 
reported. For journal articles, we additionally described the 
academic discipline of the journal in a method derived from 
Stuckler et al11 and modified to create seven categories. One 
reviewer (M.H.B.) coded all studies, with 30% of the studies 
coded by a second reviewer (M.C., H.T., or P.C.) as a check 
for quality and consistency.
Quality Assessment
One reviewer (M.H.B.) appraised all studies with 30% 
of the studies appraised by a second reviewer (M.C., H.T., 
or P.C.) as a check for quality and consistency. To date, the 
only formally developed and validated quality assessment 
tool specific to regression discontinuity designs has been 
produced by What Works Clearinghouse (WWC), an online 
resource center funded by the United States Department of 
Education.12 The 2010 version (1.0) of the WWC standards 
for regression discontinuity designs comprises three screen-
ing questions (“qualifying criteria”) and four standards that 
each involve multiple criteria. According to the WWC Stan-
dards, studies that do not meet the three qualifying criteria 
are not considered valid regression discontinuity designs. 
However, in this review we applied all quality assessment cri-
teria to each study, irrespective of whether it met the qualify-
ing criteria, given that failure to meet the third criterion in 
particular may have reflected inadequate reporting rather than 
a genuinely confounded forcing variable. We further adapted 
the WWC tool by only judging whether individual criteria 
were satisfied and not whether the overall standards were met, 
rephrasing multi-component criteria as single-component yes 
or no questions, and by omitting optional criteria that are only 
intended to apply under specific study conditions. We did not 
apply the WWC standard for attrition, which requires evalu-
ations of educational interventions using regression discon-
tinuity designs to report study attrition in the same manner 
as randomized controlled trials, because nearly all regression 
discontinuity designs in health were retrospective analyses 
of existing datasets rather than prospective studies. Answers 
of yes, no, or unclear were recorded for the eight resulting 
criteria:
(1) Was a forcing variable used for treatment assignment?
(2)  Was the forcing variable ordinal with at least four 
unique values on either side of the cutoff?
(3)  Was the forcing variable cutoff used only for assign-
ment to the treatment under investigation, and not to 
other treatments simultaneously?
(4) Was there a description of how the forcing variable was 
scored and how treatment assignment occurred?
(5) Was smoothness of the forcing variable around the 
cutoff investigated?
(6) Did the study compare baseline measurements of key 
covariates for treated and non-treated groups?
(7) Were falsification tests conducted?
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(8) Were robustness checks of the statistical model con-
ducted, such as sensitivity analyses relating to band-
width selection and functional form?
Criteria 1, 2, and 3 relate to conditions for valid imple-
mentation of regression discontinuity designs with sufficient 
data points to model the relationship between the forcing var-
iable and the outcome. If the cutoff is used to assign partici-
pants to multiple treatments simultaneously, for example when 
family income is used to assess eligibility for several benefits, 
the forcing variable is said to be confounded and regression 
discontinuity designs cannot be used to evaluate the effect 
of any one of those treatments alone (although they could be 
used to evaluate the effect of the totality of the treatments).
Criteria 4 and 5 relate to investigation of how the forcing 
variable was implemented in the context under investigation. 
The study should have a description of the scoring and assign-
ment process that supports the integrity of the forcing variable, 
i.e. a narrative account showing that treatment assignment was 
not open to manipulation. This narrative should be supported 
by a histogram or density test that demonstrates smoothness 
of the forcing variable around the cutoff (bunching on either 
side could suggest manipulation).
Criterion 6 relates to the potential for selection bias in 
the study. Criterion 7 relates to falsification tests, which may 
look for unexplained discontinuities at values other than the 
cutoff or check for discontinuities at the cutoff in outcomes 
that ought not to have been affected by the intervention.
Criterion 8 assesses the quality of the statistical anal-
ysis. As the results of regression discontinuity design analyses 
are sensitive to model specification, robustness checks of the 
model should be conducted, for example through sensitivity 
analyses.
Data Synthesis
We conducted a narrative synthesis that aimed to de-
scribe patterns and commonalities across studies. The main 
method of narrative synthesis used was thematic summary, in 
which a descriptive coding framework is developed to allow 
the grouping of studies in order to compare their character-
istics.13 Count data were collected in relation to numbers of 
publications by year, by topic, and by academic discipline to 
enable identification of trends in the use of regression discon-
tinuity designs.
RESULTS
Quantity of Studies Using Regression 
Discontinuity Designs in Health
eFigure 1; http://links.lww.com/EDE/B738 in the sup-
plemental digital content shows the study selection process 
as a flowchart. The searches retrieved 7658 records, of which 
5049 were duplicates. Of the unique records, we excluded 
2305 (1784 abstracts and 521 full-text articles screened) be-
cause they did not meet the inclusion criteria. We identified 21 
additional studies through examination of full text: 19 from 
the reference lists of full-text articles, and two doctoral the-
ses that each contained two separate RD studies. In total, 325 
studies were included.
The number of studies published by year (Figure 1) 
shows that the use of regression discontinuity designs in 
health-related applications is increasing over time, with the 
greatest increase in output taking place in the past decade.
Topics and Academic Disciplines of Publications
eTable 2; http://links.lww.com/EDE/B738 in the sup-
plemental digital content provides an overview of the syn-
thesis, with studies organized by subject area and by the type 
of intervention or exposure under investigation. Detailed 
characteristics of the included studies, including context, 
forcing variable used, intervention or exposure, and out-
comes, along with references for all 325 studies, appear in 
eTables 3–12; http://links.lww.com/EDE/B738 in the supple-
mental digital content.
One-third (106/325; 33%) of included studies investi-
gated public health policy-related questions (other than health 
insurance programs), namely alcohol policies (n = 25), the or-
ganization of health services (n = 26), disease prevention and 
screening (n = 13), early years interventions (n = 11), nutri-
tional exposures or interventions (n = 11), tobacco (n = 8), air 
quality (n = 7), and road safety (n = 5). The public health policy 
issue investigated by the largest number of studies was min-
imum legal drinking age legislation (n = 24). One-third of the 
studies evaluated either health insurance programmes (n = 54) 
or the health effects of education (n = 54). The remaining 
studies considered clinical treatments in physical (n = 23) or 
mental health (n = 8), the health effects of social programs 
in low- and middle-income (n = 35) or high-income (n = 23) 
countries, and health effects of (non-interventional) exposure 
to disasters, social conditions, or family conditions (n = 22).
More than two-thirds (230/325; 71%) of the publica-
tions identified appeared in peer-reviewed journals, with the 
remainder identified from gray literature sources (including 
52 working articles, 37 theses, two reports, two book chapters, 
and two conference articles). Of the peer-reviewed articles, 
over half (127/230; 55%) appeared in journals indexed in Web 
of Science as economics or health economics journals. Just 
over one-third (113/325; 35%) of the included studies were 
indexed in Medline at the time of the search.
The geographic coverage of regression discontinuity 
design output is global, with authors and data from six con-
tinents represented in the included studies, but dominated 
by the United States: over half of the publications (186/325; 
57%) had a first author affiliated with a US institution and 
nearly half (134/325; 41%) used US data for analysis.
Thematic Analysis of Forcing Variables and 
Threshold Rules
Analysis of the study designs focused on the forc-
ing variable as it is a fundamental requirement of regression 
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discontinuity designs. Thematic analysis of the forcing vari-
ables demonstrated that six types of variable have been used to 
apply these designs in the study of health outcomes:
(1) age;
(2) socioeconomic measures such as poverty indices, lit-
eracy rates, or income;
(3) clinical measures that act as a threshold for an 
intervention;
(4) environmental measures;
(5) geographic location; and
(6) date or time.
For a regression discontinuity design to be implemented, 
a threshold rule must exist according to which the value of 
the forcing variable is used to assign people or study units 
into treated and untreated groups. Thematic analysis demon-
strated that four sources of threshold rules are common to the 
included studies:
(1) program eligibility rules for social programs and other 
complex interventions;
(2) clinical decision-making rules or guidelines;
(3) thresholds imposed by legislation to enable or restrict 
activities that affect health; and
(4) date or time of the implementation or occurrence of 
changes or events (such as policy changes or natural 
disasters) that produce a change in exposure status.
The Table provides examples of each type of forcing 
variable and of the threshold rules used.
Quality Assessment
The eight quality assessment criteria were fully met 
by 12% (40/325) of the studies (Figure 2). Fifteen percent 
(49/325) of studies reported a pre-specified primary outcome 
or study protocol.
Almost all studies (323/325; 99%) clearly reported the 
forcing variable used (criterion 1) and most (295/325; 91%) 
reported the use of at least four discrete values of the forcing 
variable on either side of the cutoff value (criterion 2). In the 
included studies, 172/325 (53%) provided enough informa-
tion to support a conclusion that the forcing variable was not 
confounded, 13/325 (4%) used a cutoff that was clearly used 
to assign people to additional treatments other than the one 
under investigation, and 140/325 (43%) used a forcing vari-
able that could conceivably be confounded without reporting 
clear evidence to the contrary (criterion 3).
Of the included studies, 291/325 (89%) provided some 
account of scoring and treatment assignment demonstrating 
the integrity of the forcing variable (criterion 4), and 158/325 
(49%) reported a density test or histogram of the forcing var-
iable (criterion 5).
Just over two-thirds of studies (224/325; 69%) exam-
ined whether treatment and control groups showed baseline 
equivalence on any covariates (criterion 6), but less than half 
(152/325; 47%) conducted falsification tests (criterion 7).
Finally, over three-quarters (256/325; 79%) of studies 
reported robustness checks (criterion 8).
DISCUSSION
Key Findings
Through a comprehensive search of 32 databases, this 
systematic review has identified 325 studies that apply regres-
sion discontinuity designs to investigate health-related research 
questions. The findings confirm that the designs are suitable for 
evaluation of health interventions and health policy, while also 
FIGURE 1. Histogram of regression discontinuity studies of health outcomes published by year between January 1980 and 
January 2019.
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showing that they have been more widely applied in health re-
search than previously appreciated. The synthesis identified six 
categories of forcing variable (age, date/time, socioeconomic 
measures, clinical measures, environmental measures, and geo-
graphic boundaries) and four types of threshold rules (program 
eligibility, treatment thresholds, legislated thresholds, and dates 
TABLE. Thematic Analysis of Forcing Variables and Threshold Rules Used in Regression Discontinuity Studies of Health Outcomes
Type of Forcing Variable Number of Studies Measurement Used Threshold Rule
Age 110 Age in days, months, weeks, or years Age threshold for:
•  Starting school
•  Leaving school
•  Legal drinking age
•  Treatment or benefit eligibility
•  Insurance eligibility
•  Retirement
Date/time 107 Calendar date, month, or year
Time in minutes, hours, or days
Date or time of:
•  Implementation of policy/ legislation
•  Repeal of policy/legislation
•  Disaster or major incident
•  Change in situation or conditions





Poverty or literacy rate
Poverty or welfare index
Predicted probability of borrowing microcredit
Program quality score
Vote share or margin
Benefit or program eligibility
Election outcome
Legislated threshold

















Risk threshold for intervention
Guideline threshold for intervention
Legislated threshold for intervention
Environmental measure 6 Ozone forecasts
Air pollution levels
Policy threshold for action
Legislated threshold for action









Policy threshold for intervention/
exposure
Program eligibility
Although 325 studies are included in the review, the total number of analyses is 326 because one study conducted two RD analyses using two different forcing variables (age and date).
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of implementation) that have been used to implement regres-
sion discontinuity designs in health studies.
In assessing the quality of these studies against eight cri-
teria specific to regression discontinuity designs, this review 
demonstrates the need for improvement in the design and re-
porting of studies that use regression discontinuity. The most 
frequently encountered issues in study quality related to un-
clear reporting of how treatment assignment occurred, failing 
to show clearly that the forcing variable was not manipulated 
or confounded, not reporting a density test or histogram of the 
forcing variable, and not reporting any falsification tests (i.e., 
looking for discontinuities at non-cutoff values of the forcing 
variable or in outcomes that ought not to be affected by the 
treatment). These are not trivial issues, as they assess whether 
the key identifying assumptions of the design have been met 
and therefore, whether any effect can plausibly be attributed to 
the intervention or exposure under investigation.
Contribution to Knowledge About Regression 
Discontinuity Designs and Natural Experiments
In addition to the varied performance against the quality 
criteria, some limitations of regression discontinuity designs 
are apparent which may need to be considered in future ev-
idence synthesis work and further development of standards 
of reporting. Previously the chief limitation of the design, 
apart from the perceived difficulty of finding situations in 
which it could be used, was thought to be the need for large 
sample sizes to achieve adequate statistical power. Many of 
the studies examined in this review used very large datas-
ets and thus sample size was less of a concern. However, by 
exploring functional form and conducting robustness checks 
in the absence of a study protocol or prospectively chosen 
primary outcome, many studies inadvertently created prob-
lems in terms of transparency, interpretation, and synthesis. 
Studies using regression discontinuity designs frequently 
present the results of multiple analyses, including different 
stratification of data (e.g., by gender or age), different choices 
of bandwidth, and different model specifications. While ro-
bustness checks are recommended, they may inadvertently 
create a risk of data-dredging in the primary study, and of 
bias in the selection of results for inclusion in subsequent ev-
idence synthesis.
By identifying a large number of studies that evaluate 
clinical interventions, national policy changes, and effects of 
social determinants of health, this review offers substantial 
evidence that regression discontinuity designs have greater 
applicability in health research or policy evaluation than 
has previously been appreciated.8,9 This review joins a small 
number of other systematic reviews that have investigated the 
application of innovative non-randomized study designs and 
natural experiment methods to medicine, epidemiology, and 
public health. This review identified more examples of re-
gression discontinuity designs than another systematic review 
identified of instrumental variable studies in epidemiology 
and medicine, suggesting that, although good instruments 
may be hard to find, good forcing variables may be less so.14 
These findings also support the conclusion of Moscoe et al9 
that regression discontinuity designs are probably under-used 
in health research: although numerous relevant applications 
of the design can be identified, few have been replicated or 
extended to other contexts, and the results suggest that the 
FIGURE 2. Summary of quality assessments of regression discontinuity studies that report health outcomes. The bar chart shows 
the number of studies (total = 325) judged as yes, no, or unclear as to whether they meet eight criteria derived from the What 
Works Clearinghouse Standards for RD Version 1.0 (Schochet et al., 2010). FV, forcing variable.
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potential to do so exists. Also, regression discontinuity designs 
are not yet as commonly applied as, for example, propensity 
score matching has been in medicine; a systematic review on 
that topic identified 296 studies published in a 6-month period 
in PubMed alone.15
Strengths and Limitations
The strengths of this review include systematic search-
ing of 32 databases and critical appraisal of included studies 
against eight design-specific criteria, leading to a comprehen-
sive overview of regression discontinuity designs in health. 
The review was conducted according to a protocol registered 
in PROSPERO with no significant deviations from the pro-
tocol. The unexpectedly large number of studies meeting the 
inclusion criteria led to the study’s main limitation, which was 
the lack of resource necessary to involve two reviewers in all 
steps of study selection and critical appraisal. However, this 
limitation was addressed by double-sifting a random sample 
of the search results, piloting the critical appraisal method 
with two reviewers, and having two reviewers appraise and 
extract data from 30% of studies as a check for quality and 
consistency.
Implications
This review has two main implications for research-
ers interested in identifying natural experiments or imple-
menting regression discontinuity designs. First, we offer a 
comprehensive overview of forcing variables and threshold 
rules used in regression discontinuity studies with health out-
comes, which may help researchers to identify situations in 
which these designs may be used to evaluate interventions or 
policies. Second, we show the strengths and weaknesses of 
the existing literature in terms of study quality, which point 
to several considerations that researchers should take into 
account in order to produce high-quality evidence using re-
gression discontinuity designs. Researchers should provide 
a full account of the choice of forcing variable and how it 
was implemented in the context of the study setting; provide 
evidence that treatment assignment was free from manipu-
lation; state whether the same value of the forcing variable 
was used simultaneously to assign the participants to other 
treatments that could affect the outcome; explore the sensi-
tivity of results to bandwidth choice and model specification; 
and investigate and rule out rival hypotheses.16 A report of a 
potentially valid design may undermine its own conclusions 
if it fails to demonstrate that the assumptions of regression 
discontinuity designs, particularly the unconfoundedness of 
the forcing variable, are met. Our results point to the need for 
reporting standards for regression discontinuity designs to 
improve quality, as STROBE and CONSORT have achieved 
with other study designs.
CONCLUSIONS
This systematic review provides a detailed illustration 
of how regression discontinuity designs can be implemented 
to investigate the effects of a wide range of interventions and 
exposures on health outcomes. We have conducted an exhaus-
tive search of 32 databases to provide the most comprehensive 
review to date of the use of these designs in public health and 
related policy areas. We have identified substantially greater 
use of regression discontinuity designs in health than has 
been previously recognized, demonstrating the relevance to 
health research and wide potential scope for application of the 
method, while highlighting substantial shortcomings in study 
reporting.
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